CES2 and metabolic disease: Although recent advances demonstrated the relevance of carboxylesterases, mainly the CES1/Ces1 and CES2/Ces2 families, to metabolic diseases such as obesity and fatty liver disease, differences and similarities among carboxylesterases were elucidated.